Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet Lond Engl. 2012;380:1606–1619.

Article  Google Scholar 

C LB, S H, L P-B. Ulcerative colitis. Lancet Lond Engl [Internet]. 2023 [cited 2024 Feb 16];402. Available from: https://pubmed.ncbi.nlm.nih.gov/37573077/

Dubois E, Moens A, Geelen R, Sabino J, Ferrante M, Vermeire S. Long-term outcomes of patients with ulcerative proctitis: analysis from a large referral centre cohort. United Eur Gastroenterol J. 2020;8:933–941.

Article  Google Scholar 

Kato S, Ishibashi A, Kani K, Yakabi K. Optimized management of ulcerative proctitis: when and how to use mesalazine suppository. Digestion. 2018;97:59–63.

Article  PubMed  CAS  Google Scholar 

Mr L, Sl K, Be H, Cj van der W. Drug therapies for ulcerative proctitis: systematic review and meta-analysis. Inflamm Bowel Dis [Internet]. 2014 [cited 2024 Feb 28];20. Available from: https://pubmed.ncbi.nlm.nih.gov/25072502/

Calafat M, Lobatón T, Mañosa M, Marín L, Caballero N, Larraín M et al. Therapeutic requirements in active ulcerative proctitis: a single-centre study. Gastroenterol Hepatol. 2017;40:663–668.

Article  PubMed  Google Scholar 

Kruis W, Siegmund B, Lesniakowski K, Simanenkov V, Khimion L, Sobon M et al. Novel budesonide suppository and standard budesonide rectal foam induce high rates of clinical remission and mucosal healing in active ulcerative proctitis: a randomised, controlled. Non-inferiority Trial J Crohns Colitis. 2022;16:1714–1724.

Article  PubMed  Google Scholar 

Lie MRKL, Kreijne JE, Dijkstra G, Löwenberg M, van Assche G, West RL et al. No superiority of tacrolimus suppositories vs beclomethasone suppositories in a randomized trial of patients with refractory ulcerative proctitis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2020;18:1777-1784.e2.

CAS  Google Scholar 

Watanabe M, Nishino H, Sameshima Y, Ota A, Nakamura S, Hibi T. Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation: a placebo-controlled study. Aliment Pharmacol Ther. 2013;38:264–273.

Article  PubMed  CAS  Google Scholar 

Meucci G, Vecchi M, Astegiano M, Beretta L, Cesari P, Dizioli P et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Am J Gastroenterol. 2000;95:469–473.

Article  PubMed  CAS  Google Scholar 

Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. N Engl J Med. 1987;317:1625–1629.

Article  PubMed  CAS  Google Scholar 

Travis SPL, Schnell D, Krzeski P, Abreu MT, Altman DG, Colombel J-F et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013;145:987–995.

Article  PubMed  Google Scholar 

Walsh E, Chah YW, Chin SM, Lochhead P, Yajnik V, Denmark V et al. Clinical predictors and natural history of disease extension in patients with ulcerative proctitis. Inflamm Bowel Dis. 2017;23:2035–2041.

Article  PubMed  Google Scholar 

Park S-K, Ye BD, Yang S-K, Kim S-O, Kim J, Kim JW et al. Clinical features and course of ulcerative colitis diagnosed in asymptomatic subjects. J Crohns Colitis. 2014;8:1254–1260.

Article  PubMed  Google Scholar 

Cortot A, Maetz D, Degoutte E, Delette O, Meunier P, Tan G et al. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis. Am J Gastroenterol. 2008;103:3106–3114.

Article  PubMed  Google Scholar 

Heyman MB, Kierkus J, Spénard J, Shbaklo H, Giguere M. Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents. Inflamm Bowel Dis. 2010;16:1931–1939.

Article  PubMed  Google Scholar